BiotechTube
Home/Auro Vaccines/Victor Leyva-Grado
VL

Victor Leyva-Grado

Director of Pre-clinical Immunology

Auro Vaccines

Therapeutic Areas

Infectious DiseasesOncology

Auro Vaccines Pipeline

DrugIndicationPhase
PBS Vax™ PlatformVaccine Technology PlatformN/A
SARS-CoV-2 VaccinePrevention of COVID-19Poised for Clinical
Chikungunya Virus VaccinePrevention of Chikungunya infectionPoised for Clinical
HPV Therapeutic VaccineTreatment of cervical dysplasia (HPV-associated)Poised for Clinical
RSV VaccinePrevention of Respiratory Syncytial Virus infectionPreclinical
Filovirus Vaccine (Ebola)Prevention of Ebola virus diseasePhase 1
Filovirus Trivalent VaccinePrevention of all Ebola species & Marburg virusPre-IND
Nipah/Hendra Virus VaccinePrevention of Nipah/Hendra infectionResearch

Leadership Team at Auro Vaccines

JN
Jeffrey N. Meshulam
President
AM
Alan M. Gordon
Senior Patent Counsel
SH
Stefan Hamm
Vice President & Site Head
DM
Demetrius Matassov
Director of Viral Vaccine Development
View full Auro Vaccines profile